5 research outputs found
Good neurological outcome despite very low regional cerebral oxygen saturation during resuscitation - a prospective preclinical trial in 29 patients
Background Noninvasive regional cerebral oxygen saturation (rSO2) measurement
using near-infrared spectroscopy (NIRS) might inform on extent and duration of
cerebral hypoxia during cardiopulmonary resuscitation (CPR). This information
may be used to guide resuscitation efforts and may carry relevant early
prognostic information. Methods We prospectively investigated non-traumatic
out-of-hospital cardiac arrest (OHCA) patients on scene. NIRS was started
either during CPR or shortly after (<2 min) return of spontaneous circulation
(ROSC) by emergency medical service (EMS). Outcome was determined at intensive
care unit (ICU) discharge and 6 months after cardiac arrest. Results A total
of 29 OHCA patients were included. In 23 patients NIRS was started during CPR
and in 6 patients immediately after ROSC. 18 (62.1 %) patients did not reach
ROSC. Initial rSO2 during CPR was very low (<50 % in all 23 patients, < 30 %
in 19 of 23 patients) with no significant difference between patients
achieving ROSC and those who did not. Of five patients with ROSC, in whom NIRS
was recorded during CPR, two reached a good six-months outcome (initial rSO2
22 %) and three died during the ICU stay (initial rSO2 15, 16 and 46 %). In
six patients with NIRS started immediately after ROSC (<2 min), rSO2 was
substantially higher (54–85 %) than in patients during CPR (p = 0.006).
Discussion and conclusion Initial frontal brain rSO2 determined by NIRS during
CPR was generally very low and recovered rapidly after ROSC. Very low initial
rSO2 during CPR was compatible with good neurological outcome in our limited
cohort of patients. Further studies are needed to assess in larger cohorts and
more detail the implications of very low initial rSO2 during CPR on scene
Good neurological outcome despite very low regional cerebral oxygen saturation during resuscitation—a prospective preclinical trial in 29 patients
Evidence for Histone Eviction in trans upon Induction of the Yeast PHO5 Promoter
The yeast PHO5 promoter is a model system for the role of chromatin in eukaryotic gene regulation. Four positioned nucleosomes in the repressed state give way to an extended DNase I hypersensitive site upon induction. Recently this hypersensitive site was shown to be devoid of histone DNA contacts. This raises the mechanistic question of how histones are removed from the promoter. A displacement in trans or movement in cis, the latter according to the well established nucleosome sliding mechanism, are the major alternatives. In this study, we embedded the PHO5 promoter into the context of a small plasmid which severely restricts the space for nucleosome sliding along the DNA in cis. Such a construct would either preclude the chromatin transition upon induction altogether, were it to occur in cis, or gross changes in chromatin around the plasmid would be the consequence. We observed neither. Instead, promoter opening on the plasmid was indistinguishable from opening at the native chromosomal locus. This makes a sliding mechanism for the chromatin transition at the PHO5 promoter highly unlikely and points to histone eviction in trans
Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes
Phagocytosis of apoptotic, senescent, and dying cells by macrophages is a well characterized process. More recently it has been shown that in addition to macrophages vital neighboring cells in the affected tissue participate in the cellular clearance. While scavenger receptors have been shown to mediate uptake into macrophages, it is poorly understood how cellular debris is internalized by nonprofessional phagocytes. We here analyze the endocytic activity of vital fibroblasts and epithelial cells exposed to cellular debris and membrane remnants. We show a mutual stimulation in the endocytosis of debris and apolipoproteinJ (clusterin) in these cells. Experiments using RAP (receptor-associated protein) to block ligand binding to LRP and megalin as wel